Conditions: Hypercholesterolemia Dyslipidemia
Keywords: Hypercholesterolemia dyslipidemia high cholesterol LDL antibody PCSK9 PF-04950615 RN316
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 46
Healthy volunteers: no

Brief summary:
PF-04950615 is a new investigational hypercholesterolemic agent that is being tested in this study to evaluate if it can lower LDL cholesterol.

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None

Interventions: intervention 1: Placebo intervention 2: PF-04950615 (RN316) intervention 3: PF-04950615 (RN316)
Intervention descriptions: intervention 1: An infusion lasting approximately 60 minutes intervention 2: An infusion lasting approximately 60 minutes intervention 3: An infusion lasting approximately 60 minutes

Protocol document: